🔴 Hims & Hers Health is trading 10.51% down today after mixed FDA advisory vote on peptide products

Hims & Hers Health is trading at €22.48 (-10.51%) amid renewed pressure tied to FDA scrutiny of its peptide products.

• The move follows a mixed FDA Pharmacy Compounding Advisory Committee vote on seven peptides central to the company’s compounding business.
• Sentiment remains weak as the stock continues its pullback from the prior session’s sharp decline.